Page last updated: 2024-10-24

chlorambucil and Hypoproteinemia

chlorambucil has been researched along with Hypoproteinemia in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Hypoproteinemia: A condition in which total serum protein level is below the normal range. Hypoproteinemia can be caused by protein malabsorption in the gastrointestinal tract, EDEMA, or PROTEINURIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WERDEGAR, D1
ADLER, H1
WATLINGTON, C1

Other Studies

1 other study available for chlorambucil and Hypoproteinemia

ArticleYear
ENTERIC PROTEIN LOSS WITH HYPOPROTEINEMIA IN DIFFUSE LYMPHOSARCOMA OF THE BOWEL.
    Annals of internal medicine, 1963, Volume: 59

    Topics: Aged; Biopsy; Blood Protein Disorders; Chlorambucil; Edema; Humans; Hypocalcemia; Hypoproteinemia; I

1963